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ABSTRACT
Saccharomyces cerevisiae telomerase-negative
cells undergo homologous recombination on sub-
telomeric or TG1–3 telomeric sequences, thus allow-
ing Type I or Type II post-senescence survival,
respectively. Here, we find that the DNA damage
sensors, Mec1, Mec3 and Rad24 control Type II
recombination, while the Rad9 adaptor protein and
the Rad53 and Chk1 effector kinases have no effect
on survivor type selection. Therefore, the Mec1 and
Mec3 checkpoint complexes control telomeric
recombination independently of their roles in gen-
erating and amplifying the Mec1-Rad53-Chk1 kinase
cascade. rfa1-t11 mutant cells, bearing a mutation
in Replication Protein A (RPA) conferring a defect
in recruiting Mec1-Ddc2, were also deficient in
both types of telomeric recombination. Importantly,
expression of an Rfa1-t11-Ddc2 hybrid fusion
protein restored checkpoint-dependent arrest, but
did not rescue defective telomeric recombination.
Therefore, the Rfa1-t11-associated defect in telom-
eric recombination is not solely due to its failure to
recruit Mec1. We have also isolated novel alleles of
RFA1 that were deficient in Type I but not in Type II
recombination and proficient in checkpoint control.
Therefore, the checkpoint and recombination func-
tions of RPA can be genetically separated, as can
the RPA-mediated control of the two types of
telomeric recombination.
INTRODUCTION
Telomeres, the ends of eukaryotic linear chromosomes, are
required for overall genome stability. Telomeric DNA is made
of tandem arrays of TG-rich nucleotide repeats of variable
length depending on the organisms ( 300 bp in the yeast
Saccharomyces cerevisiae, 5–15 kb in humans) and kept at
a constant value in a given organism. Telomeric proteins,
organized around telomeric DNA, provide both telomere
end protection and processes for access of telomerase during
telomere replication (1,2). Telomere length homeostasis is
crucial for two main reasons. First, removal of the terminal
primer at the end of lagging-strand during DNA synthesis
leaves a small gap that cannot be ﬁlled in, a phenomenon
known as the ‘end-replication problem’ [e.g. see Ref. (3)].
Telomere replication, by a specialized reverse transcriptase,
telomerase (4), solves this problem by maintaining telomeres
at a constant length. Second, maintenance of telomeric tracts
of a minimal size is needed for recruitment by telomeric
DNA sequences of specialized telomeric proteins. The major
function of telomere end protection proteins is to prevent
inappropriate access of DNA repair or modiﬁcation proteins,
such as exonucleases. The processes underlying telomere rep-
lication and telomere end protection are intimately linked (5).
For instance, in yeast and humans, both telomere erosion and
telomere uncapping can trigger telomeric senescence (6,7).
Classically, inactivation of telomerase or of the yeast EST
proteins trigger telomeric senescence during which telomeres
shorten critically so as to lead to cell death after  75–100
generations (8,9). Telomeric senescence activates the DNA
damage checkpoint that ultimately leads to a cell cycle arrest
of the senescing cells at the G2/M transition (10).
In recent years, increasing interest has been focused on a
telomerase-independent mechanism for maintaining telom-
eric repeats that relies on homologous recombination between
the repeated telomeric DNA sequences (11,12). This path-
way, ﬁrst discovered in S. cerevisiae (13), allows senescing
cells deﬁcient in telomerase function, such as est or tlc1
mutants (8,9), to maintain indeﬁnitely functional telomeres,
and, hence, viability, in the absence of telomerase. These
mechanisms are receiving much attention at the moment
due to the recent ﬁnding that they are also operating in
some human tumor cells, in which they are known as the
alternative lengthening of telomeres (ALT) pathway (14).
In S. cerevisiae, the rare cells escaping telomeric senescence,
termed post-senescence survivors, use two distinct pathways
of recombination, based on the initial observation that
Rad52, essential for recombination (15), was needed for this
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telomerase-negative, otherwise wild-type, cells, a ﬁrst class
of survivors (of type I), relying on Rad51, were found to
amplify the subtelomeric Y0 elements and had very short ter-
minal tracts of TG1–3 DNA, while Rad50-dependent type II
survivors ampliﬁed the terminal TG1–3 sequences with no
evidence for rearrangement of Y0 elements (11,13,16). In
the yeast Kluveromyces lactis, small rolling circles of single-
or double-stranded telomeric DNA resulting from the resolu-
tion of an intratelomeric invasion provide one mechanism
that is responsible for the generation of the long type II
telomeres (12,17). Very recently, extra-chromosomal circles
of DNA have also been identiﬁed in both type I and type II
post-senescent survivor S. cerevisiae cells (18). In addition
to these recombination-dependent pathways of survival to
telomeric senescence, S. cerevisiae telomerase-negative cells
have also been shown to utilize recombination-independent
pathways that involved repair of DNA double-strand break
by palindromic DNA structures (19).
A number of factors have been found to affect the selection
of the survivor type in S. cerevisiae. In most of these cases,
factors affecting telomere end protection or the processing
of damaged telomeric DNA were implicated (11,20,21).
Interestingly, the checkpoint proteins of the phosphatidyl-
inositol 3-kinase-like family, Mec1 and Tel1 (homologues
to the human ATR and ATM, respectively), have been
recently found to be required for type II recombination in
S. cerevisiae (22). Here, we focused our attention on the role
of Mec1, as well as that of other checkpoint proteins, in
survivor type selection. We also document the role of Rep-
lication Protein A (RPA) in telomeric recombination by
analyzing a particular allele of its larger subunit, rfa1-t11,
previously reported to be defective in recruiting Mec1/ATR
and Ddc2/ATRIP at sites of damaged DNA (23), as well as
in recombination (24). Finally, we have isolated separation-
of-function rfa1 mutants that exhibit checkpoint proﬁciency
but telomeric recombination defects.
MATERIALS AND METHODS
Yeast strains and plasmids
All strains used in this study were in the BF264-15D genetic
background used in our laboratory (25). The rfa1::KanMX4/
RFA1, chk1::KanMX4, ddc1::KanMX4, rad51::KanMX4
and rad59::KanMX4 strains were purchased at Euroscarf
(Frankfurt, Germany). The rfa1-t11 allele, from the Kolodner
lab (24), was integrated at the RFA1 locus after cutting
with NheI. In all experiments rfa1-t11 was integrated at the
RFA1 locus, after cutting with NheI. The mec1::TRP1
sml1::KanMX4 and rad53::TRP1 sml1::KanMX4 mutant
strains are from the Hartwell and Emili laboratories (26,27).
The tlc1::LEU2 was from the Gottschling laboratory (28).
The rad50::hisG-URA3-hisG strain was from the Haber
laboratory (29). The rad9::LEU2 and cdc13-1 strains are
from the Hartwell laboratory (30). The clb2::LEU2 strain
was from the Reed laboratory (31). The mec3::TRP1 strain
was from the Lucchini laboratory (32). The rad17::URA3
and rad24::URA3 strains were from the Friedberg laboratory
(33). Yeast cells were grown in yeast extract-peptone-
dextrose (YEPD) medium at 30 C unless otherwise indicated.
The integrative TRP1-based pRS304 RAD53-2 HA construct
(containing the last 344 nt, out of 2463 nt total of RAD53), a
generous gift from Andrew Emili (26,27), was used as such
and also subcloned into YIp211 (integrative URA3 plasmid)
and integrated at the RAD53 locus after cutting with HpaI.
The integrative YIp-352-mec1-kd (URA3) construct, contain-
ing the last  2.3 kb, out of  7.1 kb total, of MEC1 in which
two substitutions in the kinase domain [D-A at position 2224
and N-K at position 2229 had been introduced (34,35), a kind
gift from Akira Matsuura (35)], was integrated at the MEC1
locus after cutting with NruI. Actual introduction of the muta-
tions was veriﬁed by sequencing the sequence of interest
at the MEC1 locus. CLB2, CLB2-2 HA and RAD52 were
expressed either from an integrative, centromeric (CEN) or
episomal (2 m) plasmid under the control of their own respec-
tive promoters.
Analysis of telomere organization and structure
Genomic DNAs were prepared, separated in a 0.9% agarose
gel (in TBE) run in TBE buffer overnight and, after denatura-
tion, transferred onto nitrocellulose membrane and immobi-
lized by baking at 80 C for 1 h, as described previously
(25). The membrane was then pre-hybridized in 6· SSC,
0.1% SDS, 1% non-fat milk and hybridized with a 270 bp
TG1–3
32P-labeled telomeric probe. Following digestion with
XhoI, to cut within the Y0 regions of chromosomes (36),
telomere tracts of wild-type cells appear as a broad-band of
 1.2–1.3 kb, which represents the average length of most
chromosomes, those containing Y0 subtelomeric regions.
From non-Y0 chromosomes, XhoI cutting typically generates
fragments migrating at  2.1, 2.3, 3.3 and 3.9 kb in Southerns.
In senescing cells, the disappearance of the non-Y0 fragments
attests to the fact that survivors have arisen by homologous
recombination [see, for instance, Ref. (16)]. In some experi-
ments, genomic DNA was digested with a mixture of four
restriction enzymes (AluI, HaeIII, HinfI and MspI) using a
4 bp recognition sequence and the Southern revealed with a
TG1–3 probe. Since these enzymes cut within telomeric Y0
sequences but not within the TG1–3 sequences, they are cur-
rently used to conﬁrm identiﬁcation of type II telomeres (16).
In some cases, a
32P-labeled Y0 probe was used. Results were
analyzed using a Storm PhosphorImager (Amersham Bio-
sciences) and ImageQuant.
Analysis of the kinetics of senescence/survival and
of growth rates
Telomerase-negative cells undergo senescence in 75–100
generations (9). In all kinetics, senescence of tlc1D haploid
mutant cells, and of their derivatives, was initiated after the
tlc1D/TLC1
+ diploids or their derivatives were induced to
sporulate. In the ‘liquid assays’, selected spores of the desired
genotype were individually propagated for over 100 genera-
tions as exponentially growing liquid cultures that were,
under standard conditions, diluted to 10
5 cells/ml every day.
In some experiments, wherever indicated, liquid cultures of
senescing cells were diluted to 10
6 or 10
7 cells/ml every
day, as described previously (31). Under such conditions,
telomeric senescence took place in the liquid culture, thus
resulting in a mixture of both possible survivor types and
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occurs in telomerase-negative cells, due to a selective growth
advantage of types II (16). In ‘streak assays’, which allowed
the detection of both type I and type II survivors, re-streaking
of single colonies on a YEPD agar-based plate was repeated
every 48 h (typically, cells underwent  25 generations per
streakout or passage at 29 C) to allow loss of viability and
appearance of survivors (16,37). The occurrence of senes-
cence was determined from analyzing the progression with
time of the growth rate or from the appearance of post-
senescence survivors on the plates, as well as from the
analysis of telomere structure by Southern blotting with a
telomeric probe, as described above.
Construction of fusion proteins
Plasmids expressing the Rfa1-t11-Rad52, Rfa1-t11-Ddc2 and
Rfa1-t11-HA in-frame fusion proteins were constructed by
cloning in a single-copy, centromeric, plasmid the entire ORF
of the ﬁrst part of the hybrid protein plus upstream promoter
sequences, in front of the ORF, (which included its natural
stop codon) of the second part of the hybrid protein, as
described previously (38). The codon for the ﬁrst amino
acid of the second protein in the hybrid construct was directly
following the codon for the last amino acid of the ﬁrst pro-
tein, in reading frame with it.
Construction of checkpoint-proficient, recombination-
deficient alleles of RFA1
The entire RFA1 ORF plus 267 bp upstream of the ATG and
306 bp downstream of the stop codon were ampliﬁed by PCR
under the following mutagenic conditions. The concentration
of dNTPs was either kept as in standard conditions (200 mM
each) or one of the dNTP concentration changed to 500 mM,
those of the other three were kept to 200 mM and, in both
cases, the concentration of MgCl2 was changed from 1.5 to
3.0 or 4.0 mM. Standard Taq polymerase and PCR buffer
(Invitrogen) were used. Following a 30-cycle ampliﬁcation,
the PCR products were cleaned and, according to the gap
repair method, transformed directly into rfa1::Kan-MX4
YCp33-RFA1-URA3 (including promoter sequences, ORF and
post-stop sequences) strains, together with another centro-
meric LEU2 plasmid (YCp111) made linear by digestion with
NdeI and carrying RFA1 ﬂanking regions at each extremity:
region  267 to +166 (position of an endogenous NdeI site)
at one end, and region +2000 to +2169 (position of another
endogenous NdeI site) (the TAA stop codon starts at position
+1861) at the other end. Thus, sequences upstream and down-
stream of RFA1 were available for homologous recombina-
tion, while all of RFA1 ORF (with the exception of the
ﬁrst 166 bp) were available for PCR-based mutagenesis.
Cells were plated onto leucine-lacking medium at 25 C.
Around 10000 transformants grew up which were transferred
to leucine-lacking liquid medium and then plated on 5-FOA-
containing medium at 25 C in order to force the loss of the
YCp33-RFA1-URA3 plasmid. Growing colonies were then
re-streaked on YEPD medium and then analyzed for possible
defects in telomeric recombination, as explained above, after
introduction, by crossing, of a telomerase-negative (tlc1D)
mutation. Selected mutants were again crossed to a cdc13-1
strain that also contained RAD53-2 HA integrated at the
RAD53 genomic locus and checkpoint activation assessed
by analyzing Rad53 phosphorylation following immunopre-
cipitation and western blotting using anti-HA antibodies, as
explained below.
Immunoprecipitation and immunoblotting
Proteins were immunoprecipitated from yeast cell extracts
and separated by electrophoresis, as described previously
(39). All strains analyzed harbored a chromosomal copy of
RAD53 tagged in 30 with 2 HA epitope, the corresponding
integrative plasmid being a generous gift from Andrew
Emili (26,27). Mouse monoclonal anti-HA raw ascites ﬂuid
(BabCo, 16B12, Eurogentec) and mouse anti-HA monoclonal
12CA5 antibody (Roche) were used for immunoprecipitation
and western blotting, respectively. Monoclonal mouse anti-
actin antibody (clone C4) from MP Biomedicals was pur-
chased at ICN Pharmaceutical. Blotted proteins were detected
by chemiﬂuorescence via ﬂuorescein-labeled anti-mouse sec-
ondary antibodies and a tertiary anti-ﬂuorescein alkaline
phosphatase conjugate (ECF western blotting kit, Amersham
Biosciences) and signals analyzed using a Storm Phosphor-
Imager (Amersham Biosciences) and ImageQuant.
RESULTS
Checkpoint proteins affect recombination in survivors
from telomerase-negative cells
A very small percentage of S. cerevisiae telomerase-negative
cells (here we used tlc1D cells, deleted for the RNA subunit
of telomerase, throughout) survive telomere erosion by per-
forming recombination between telomeric sequences (13).
Two types of recombination can be generated (Figure 1A).
Type I involves recombination between the homologous sub-
telomeric sequences Y0 and, in telomerase-negative, otherwise
wild-type, cells, is Rad51-dependent, while type II involves
recombination between the telomeric TG1–3 sequences and
is Rad50- and Rad59-dependent (11). It is currently agreed,
as previously explained in detail (16,22), that the type I
telomere pattern is most easily visualized by XhoI digestion
Southern blot analysis. XhoI cleaves 0.9 kb from the 30 end
of the Y0 element yielding a  1.3 kb terminal fragment
corresponding to the distal part of the Y0 element plus the
 0.3–0.4 kb of terminal TG1–3 tracts (Figure 1A). In type I
survivors, the TG1–3 terminal tracts have become eroded and
the XhoI-restricted terminal fragment is now  0.9–1.0 kb
long (Figure 1A). In contrast to type I survivors, type II
survivors exhibit many XhoI fragments of different sizes
[Figure 1A; (16,22)]. The terminal part of the Y0 elements
contain short TG1–3 tracts, allowing type I survivors to be
also conveniently detectable with a TG1–3 probe [Figure 1A;
(16)]. Although type II survivors grow better than type I sur-
vivors,  90% of tlc1D surviving cells display type I telom-
eres when grown on solid (agar-based) media [Figure 1A;
(16)]. On the other hand, and most importantly for the experi-
ments described below, when tlc1D surviving cells are grown
in liquid medium, 100% type II cells are typically recovered
(Figure 1A), because, due to their faster growth, which is
similar to that of wild-type cells, they quickly overtake the
population of type I survivors (16).
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the MEC3 checkpoint gene had difﬁculties in generating
type II cells, even in liquid medium. Thus, when grown in
liquid rich medium for about 130 generations (crisis occurs
 80–100 generations after inactivation of telomerase), only
 20% of tlc1D mec3D cells displayed type II telomeres
versus 100% of type II for the tlc1D MEC3
+ control (Table 1;
Figure 1B). We veriﬁed that in the mec3D background type II
Figure 1. (A) Survivors from telomerase-negative (tlc1) cells show two distinct patterns. Genomic DNAs from wild-type cells (no recombination, lane 1), type II
(lane 2) and type I (lane 3) senescing tlc1D cells were digested with XhoI and the Southern blot revealed with a TG1–3
32P-labeled probe. In both types of
survivors, the disappearance of the non-Y0 fragments (migrating at  2.1, 2.3, 3.3 and 3.9 kb) attests to the occurrence of homologous recombination. In type II
survivors, XhoI cutting reveals amplification of very long and heterogeneous TG1–3 sequences (lane 2), located more distal than the single XhoI site that is
present at the distal part of Y0 sequences (16). In contrast, in type I survivors telomere erosion is evident after XhoI cutting (lane 3) in comparison with the mean
size of the terminal telomere tracts in wild type corresponding to the broad band at  1.2 kb (lane 1), the amplified Y0 sequences being located more proximal than
the XhoI site, as schematically represented. (B) Mec3 inhibits the generation of type II survivors in liquid assays. Individual spores from tlc1D mec3D strains
were grown in liquid YEPD for  130 generations, at 29 C, with a daily dilution of 10
5 cells/ml (see Materials and Methods). The conversion from types I to
types II that is readily seen in liquid culture of telomerase-negative, otherwise wild-type, cells (16) was largely inhibited in the absence of Mec3. Thus, the
samples shown in lanes 12 and 13 were the only two ones, among the 15 ones shown here, to exhibit many XhoI fragments of different sizes, which entitle them
as type II survivors, those amplifying the TG1–3 tracts. tlc1D MEC3
+ cells generated 100% type II survivors (data not shown), like shown for wild-type cells in
(A) above. Analysis of telomere structure, as described above in (A), allowed to classify these 15 tlc1D mec3D spores according to the type of recombination
accomplished, I or II, as labeled below each lane.
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shown). The Mec3 complex (Ddc1 and Rad17 are the other
two components) represents, together with the Mec1–Ddc2
complex, DNA damage sensors (40,41). The Mec1 and Mec3
complexes are recruited independently to DNA double-strand
breaks (42,43). Interestingly, telomerase-negative cells bear-
ing a mec1D mutation have been previously shown to be
deﬁcient in type II recombination (22). To better document
the relationships between telomeric recombination and the
DNA damage checkpoint, we next constructed additional
checkpoint-negative telomerase-negative double mutants
and analyzed their pattern of telomeric recombination after
extended propagation in liquid cultures. Among these, tlc1D
rad17D, tlc1D rad24D and tlc1D mec1D sml1D, similarly to
tlc1D mec3D, had difﬁculties in generating type II survivors
after crisis. On the other hand, tlc1D rad9D, tlc1D rad53D
sml1D and tlc1D chk1D were fully proﬁcient in type II
recombination (Table 1). It should be noted that Rad24 is
required for the loading of the Mec3–Ddc1–Rad17 complex
(44,45). The Rad9 checkpoint adaptor and the Rad53 and
Chk1 effector kinases are subsequently activated after the
Mec1 and Mec3 complexes have bound damaged DNA
(40,41). It appears, therefore, that among the different classes
of checkpoint proteins, only the DNA damage sensors have
an effect on the type of telomeric recombination. In agree-
ment with the ﬁnding above that in mutants of the Mec3
complex type II recombination, although diminished, was still
possible, we recovered 100% type II survivors after RAD51
had been deleted in the tlc1D rad17D mutant (Table 3).
Mec1 is, together with Tel1 (homologues of ATR and
ATM in humans, respectively), a protein kinase of the
phosphatidyl-inositol 3-kinase-like family (46). In budding
yeast, phosphorylation of target checkpoint proteins by
Mec1 is necessary for initiating the DNA damage response
(26,34,47–49). To know whether Mec1 protein kinase activ-
ity was required for the control of type II telomeric recom-
bination described above, we used a kinase-dead mec1
(mec1-kd) mutant (34,35). After verifying by sequencing
actual introduction of the mec1-kd mutation at the MEC1
locus in our wild-type background, as well as associated-
hypersensitivity to the genotoxic agent methyl methane
sulfonate (MMS) and concomitant failure to activate endoge-
nous Rad53-HA (data not shown), we constructed the tlc1D
mec1-kd sml1D mutant strain and analyzed its survivor type
during post-senescence. Only around one-third of the tlc1D
mec1-kd sml1D senescing cells generated type II survivors
in liquid cultures, in contrast with the usual 100% type II
in the tlc1D MEC1
+ control (data not shown). We conclude
that, in this assay, the mec1-kd mutation behaves like a null
mec1 mutation and, therefore, the control of telomeric recom-
bination necessitates Mec1 protein kinase activity.
Overexpression of CLB2 rescues the defect in
type II recombination conferred by a mutation
in the Mec3 complex
A null mutation in CLB2, coding for the major S. cerevisiae
B-type cyclin, as well as temperature-sensitive mutations in
CDC28 (Cdk1), were recently found to confer a defect in
type II telomeric recombination (31), similar to those found
here for mec1D and mec3D mutants. We reasoned that both
mechanisms might be related and set out to establish a func-
tional link between the two events. To this end, we overex-
pressed CLB2 from an episomal plasmid (under the control
of its native promoter) in tlc1D ddc1D double mutants. As
expected, because Ddc1 is a component of the Mec3 com-
plex, tlc1D ddc1D mutants were deﬁcient in type II recom-
bination (Table 2; Figure 2A). We noted that in these
experiments with CLB2 overexpression, some of the samples
did not exhibit as clear-cut type I characteristics as usual
(Figure 2A). This may have been due to the fact that these
cells were cultivated on selective medium to maintain the
plasmid within the cells, thereby generating poorer growth
and less efﬁcient recombination. However, under identical
conditions, overexpression of CLB2 could rescue the defect
conferred by ddc1D in telomerase-negative cells to the
same extent as it did in rescuing the defect of CLB2-deleted
telomerase-negative cells (Table 2; Figure 2A). We therefore
conclude that the defect in type II recombination conferred by
a mutation in the Mec3 complex might be functionally related
to that conferred by a deﬁcit in Cdc28-Clb2.
Possible cell cycle alterations in Clb2 levels could be
invoked to explain the type II recombination defects in
telomerase-negative cells bearing a mutation in the Mec3–
Ddc1–Rad17 complex. To evaluate this possibilty, we mea-
sured Clb2 levels by immunoprecipitation of endogenous
CLB2-HA in the tlc1D ddc1D and tlc1D mutants. Clb2 levels
did not vary in the absence of Ddc1 (Figure 2B). We also
assessed CLB2-HA levels following overexpression from a
multi-copy plasmid, the same conditions as those used for
determining the survivor type in these mutants (Figure 2A).
Similar levels of overproduced Clb2 from one isolate to
the other in both strains (Figure 2C) indicated that, under
these experimental conditions, comparing the survivor type in
Table 1. Survival type frequencies in checkpoint-defective telomerase-
negative double mutants
a
Relevant genotype % of type I/% of type II
tlc1 0/100; n ¼ 22
b
tlc1 rad9 0/100; n ¼ 18
tlc1 mec3 60/40; n ¼ 25
tlc1 chk1 0/100; n ¼ 16
tlc1 rad17 80/20; n ¼ 24
tlc1 rad24 75/25; n ¼ 18
tlc1 sml1 0/100; n ¼ 12
tlc1 rad53 sml1 0/100; n ¼ 14
tlc1 mec1 sml1 50/50; n ¼ 20
aAfter  130 generations in liquid cultures at 29 C.
bn ¼ number of survivor populations tested.
Table 2. Effect of CLB2 overexpression on survival type frequencies
a
Relevant genotype % of type I/% of type II
tlc1 0/100; n ¼ 22
b
tlc1 ddc1 80/20; n ¼ 18
tlc1 clb2 100/0; n ¼ 26
tlc1 ddc1 + YEp-CLB2 50/50; n ¼ 16
tlc1 clb2 + YEp-CLB2 50/50; n ¼ 8
aAfter  130 generations in liquid cultures at 29 C.
bn ¼ number of survivor populations tested.
826 Nucleic Acids Research, 2007, Vol. 35, No. 3Figure 2. Overexpression of CLB2, the major B-type mitotic cyclin gene, rescues type II telomeric recombination in tlc1D ddc1D mutant cells. (A) Telomerase-
negative cells (tlc1) bearing a null mutation in either CLB2 (clb2) or DDC1 (ddc1), as indicated, and also overexpressing or not CLB2 (2 m plasmid, under
endogenous promoter) were propagated in liquid cultures for  130 generations, from the time the strains were created, at 29 C. As usual, this procedure resulted
in the generation of 100% type II survivors in telomerase-negative cells (tlc1) due to the growth advantage of types II over types I in liquid cultures (survivor type
has been labeled below each lane). tlc1D clb2D mutants were defective in generating type II survivors, as reported previously (31), as were tlc1D ddc1D mutants.
Overexpression of CLB2 partially corrected that defect in both tlc1D clb2D and tlc1D ddc1D. It is important to note that tlc1D clb2D mutants were somewhat
sick and grew poorly, hence the difficulty in obtaining optimal amounts of DNA for nice signals. XhoI cutting and a TG1–3
32P-labeled probe were used.
(B) Endogenous Clb2 levels remain unchanged in the absence of DDC1. Cell extracts from pre-senescent telomerase-negative cells bearing or not a mutation in
DDC1, both harvesting CLB2-HA integrated at CLB2 locus, were immuno-precipitated with anti-HA antibody and processed for western blotting with anti-HA
antibody. Various dilutions of samples were loaded, as indicated, in order to better appreciate possible variations in Clb2 levels. Quantification was done using
ImageQuant. (C) Overproduced Clb2 levels are slightly decreased when DDC1 has been deleted. Immuno-precipated CLB2-HA, expressed from a multi-copy
(episomal) plasmid under the control of native promoter in pre-senescent tlc1D clb2D and tlc1D ddc1D mutants to serve as a control for the experiment shown
above in (A), was detected as described above. The fate of these six individual clones after post-senescence recombination had occurred was followed by
Southern (XhoI cutting, TG1–3
32P-labeled probe). For each strain, two type II and one type I survivors were recorded, as shown in the lower panel.
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vant. This was expected as in the multi-copy plasmid, CLB2-
HA was under the control of its native promoter, like in the
integrative plasmid. In addition, we observed that Clb2 levels
were slightly decreased in the absence of Ddc1 (Figure 2B).
This may reﬂect a slight effect of the ddc1D mutation on
endogenous Clb2 levels, but detectable only at higher levels
of expression for reasons of increased sensitivity. Alterna-
tively, this may reﬂect the exsitence of a mechanism of con-
trol of CLB2 expression in this checkpoint-deﬁcient mutant.
We next evaluated the possibility that the type II defect
observed in telomerase-negative cells bearing a mutation in
the Mec3–Ddc1–Rad17 complex might in fact reﬂect alter-
ations in the type I recombination machinery. For instance,
it was possible that the intracellular levels of Rad51, (which
controls type I recombination) were increased in these
mutants and that this could affect telomeric recombination.
To test this hypothesis, we overexpressed RAD51 (from a
multi-copy, episomal, plasmid) in various strains and analy-
zed the pattern of telomeric recombination. This had no
visible effect as tlc1D single mutants overexpressing RAD51
still continued to produce 100% type II survivors, while over-
expression of RAD51 in tlc1D rad17D double mutants did not
alter their rate of type II defect (data not shown). It is there-
fore unlikely that the type II defect conferred by a mutation
in the Mec3–Ddc1–Rad17 complex is due to this complex
somehow inhibiting Rad51 at the telomeres.
RPA controls both types of telomeric recombination
RPA, a single-stranded DNA-binding protein essential for
DNA replication, has been implicated in a number of DNA
metabolism reactions (50,51). RPA is generally considered
to be the initial sensor of DNA damage (23,52), but, because
some studies have found that Rad51 (53) or Mre11 (54) were
recruited ﬁrst at DNA double-strand breaks, the issue is still
the matter of debate (50). RPA has been evolutionary con-
served and, in humans, consists, of three subunits, RPA70,
RPA32 and RPA14, homologues in S. cerevisiae to Rfa1,
Rfa2 and Rfa3, respectively. In yeast and humans, RPA binds
single-stranded DNA generated after resection of DNA
double-strand breaks, then Ddc2/ATRIP, thereby loading
the Mec1–ATR complex and activating the checkpoint (23).
Numerous mutants of RFA1, mainly, have been isolated
based on their sensitivity to genotoxic stress, defects in vari-
ous types of recombination or in DNA replication. Because
RPA has been recently shown to recruit Ddc2-Mec1 at sites of
DNA damage, a function lost in the rfa1-t11 mutant (23), we
chose to use the rfa1-t11 (K45E) mutant to further document
the mec1D-induced telomeric recombination defect described
above. Moreover, rfa1-t11-induced defects in recombination
and adaptation to DNA damage have been described
(15,24,50,55). As detailed in Table 3 (see also Figure 3),
telomerase-negative cells bearing the rfa1-t11 mutation
were severely affected in telomeric recombination events.
Incidentally, survivors (all of type I) from tlc1D rfa1-t11
mutants appeared when the liquid cultures were propagated
using a lower dilution [10
7 cells/ml every 24 h; Table 3;
the rate of dilution has recently been proven to be important
in such experiments; Ref. (31)]. However, intriguingly,
deletion of RAD51 (essential for type I recombination in
telomerase-negative, otherwise wild-type, cells) in tlc1D
rfa1-t11 mutants still allowed the production of survivors
(Table 3). Although we have not directly tested whether Y0
elements were ampliﬁed in these tlc1D rfa1-t11 mutants,
Table 3. Pattern of telomeric recombination in telomerase-negative rfa1-t11
mutants
a
Relevant genotype Frequency of
recombination
b
Type of
recombination
tlc1 1/10
5 II
tlc1 rad17 1/10
5 mostly I
tlc1 rad9 1/10
5 II
tlc1 rfa1-t11 1/10
7 I
tlc1 rfa1-t11 rad17 1/10
7 I
tlc1 rfa1-t11 rad9 1/10
7 I
tlc1 rad51 1/10
5 II
tlc1 rad59 1/10
5 I
tlc1 rad51 rad17 1/10
5 II
tlc1 rad59 rad17 1/10
5 I
tlc1 rad51 rfa1-t11 1/10
7 I
tlc1 rad59 rfa1-t11 N/A
c N/A
cdc13-1 tlc1 1/10
5 II
cdc13-1 tlc1 rfa1-t11 1/10
5 II
cdc13-1 tlc1 rad17 1/10
5 II
cdc13-1 tlc1 rfa1-t11 rad17 1/10
5 I
aCells were grown in liquid cultures for  150 generations, at 29 C (except for
the ts cdc13-1 strains grown at 24 C).
bCellsweredilutedevery24hat1·10
5or1·10
7cells/ml;survivorsappeared
at the indicated value when their frequency of appearance exceeded the rate
of dilution.
cN/A: recombination never occurred.
Figure 3. Effects of the recombination-deficient, checkpoint-deficient rfa1-
t11 mutation on telomeric recombination. Analysis of telomere organization
and structure by Southern blotting (see Materials and Methods), in the strains
(of the indicated relevant genotype), plus a wild-type non-senescing control
strain (wt, lane 1). Mutant cells were propagated in liquid cultures, at 29 C,
until senescence took place and beyond (a total of  130 generations), with a
daily dilution of 10
7 cells/ml. The survivor type, determined according to
criteria described in Materials and Methods and in Figure 1A, is indicated
under each lane. XhoI cutting and a TG1–3
32P-labeled probe were used.
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last lane), together with the existence of only two types of
telomeric sequences being ampliﬁed in telomerase-negative
cells, namely Y0 and TG1–3 (16), most probably identify
these survivors as type I survivors. The complete absence
of any survivor in senescing tlc1D rfa1-t11 rad59D mutants
indicated that this rfa1-t11-associated type I recombination
(atypically) relied on the Rad59 pathway (Table 3).
Targeting Rad52 at Rfa1-t11 binding sites restores
type I, but not type II, recombination
Some aspects of type II recombination are still very myster-
ious because the Rad51 recombinase, essential for strand
invasion, is dispensable during these homologous recombina-
tion processes (11,15,17). Interactions between RPA and
Rad51 (and Rad52) are relatively well understood (15,50).
On the other hand, the putative role of RPA in type II telom-
eric recombination is totally unknown. As Rad52 participates
in -and is essential for- both type I and type II recombination
(13,16,56), we set out to determine whether targeting Rad52
at the sites for binding of the recombination-deﬁcient Rfa1-
t11 protein would have the same effect on these two types of
recombination. Expression of fusion (hybrid) proteins has
been shown to represent a valuable tool to decipher telomeric
pathways (38,57). Here, we constructed an rfa1-t11-RAD52
chimeric gene and expressed it, together with the appropriate
control constructs, in tlc1D rfa1-t11 mutants. Survivors from
tlc1D rfa1-t11 p-rfa1-t11-RAD52 were generated, in the
liquid assay, while tlc1D rfa1-t11 mutants did not generate
survivors at all under identical conditions (Figure 4B).
Under the usual criteria, these survivors appeared to be of type
I, with the reserve, however, that bands in the 2.0–3.0 kb
range were still present in some isolates (Figure 4A, left
panel). In both types of survivors, the disappearance of the
non-Y0 fragments (migrating at  2.1, 2.3, 3.3 and 3.9 kb)
attests to the occurrence of homologous recombination (16).
Since in tlc1D rfa1-t11 p-rfa1-t11-RAD52 cells, some of these
bands were still visible, we set out to further characterize
these survivors. To this end, the same blot as that shown in
Figure 4A (left panel) was reprobed with an Y0 probe. The
telomeric fragments migrating at  1.1 kb, representative of
type I recombination (Figure 1A), were heavily labeled
over the background (Figure 4A, left panel). We also digested
the genomic DNA from the tlc1D rfa1-t11 p-rfa1-t11-RAD52
cells with a mixture of four base cutter restriction enzymes
that is sometimes used to identify type II recombination on
the TG1–3 substrate [(16); see also Materials and Methods].
This also identiﬁed these survivors as type I survivors
(Figure 4A, middle panel). Finally, the survivors from the
tlc1D rfa1-t11 p-rfa1-t11-RAD52 strain depended on Rad51
for their maintenance (Figure 4B), as do normal survivors
from telomerase-negative, otherwise wild-type, cells. There-
fore the Rfa1-t11-Rad52 fusion protein does rescue telomeric
recombination but leaves cells with an rfa1-t11-associated
speciﬁc defect in type II recombination.
To try to conﬁrm these ﬁndings above, we also performed
experiments with RAD52 expressed from a plasmid. Interest-
ingly, overexpression of RAD52 from a multi-copy (episo-
mal) plasmid also rescued the recombination defect in
tlc1D rfa1-t11 cells, only type I but not type II, like the
Rfa1-t11-Rad52 fusion protein (Figure 4A and B). Impor-
tantly, slight overexpression of RAD52 from a centromeric
plasmid (the same sort as that used for the rfa1-t11-RAD52
fusion experiments described above) did not rescue the
recombination defect in tlc1D rfa1-t11 cells (Figure 4B).
Therefore, in the experiments with the rfa1-t11-RAD52
fusion, the effect of Rad52 on telomeric recombination is
really due to targeting to rfa1-t11’s binding sites and not
merely to moderate increase in its intracellular amounts. In
summary, targeting of Rad52 to Rfa1-t11’s binding sites
with two different strategies produce the same phenotype,
namely selective rescue of telomeric recombination.
An Rfa1–t11–Ddc2 fusion protein restores the
checkpoint function of rfa1-t11 cells but not
its recombination function
RPA and Rad52 are likely to interact functionally and physi-
cally, thereby modulating the interactions between RPA and
Rad51 during repair of double-strand breaks by homologous
recombination (15,50), as well as during type I telomeric
recombination, as seen above. Since in wild-type cells, RPA
recruits Mec1-Ddc2 at the sites of DNA double-strand breaks,
an event that is defective in rfa1-t11 mutant cells (23), and
since mec1D cells are defective in type II recombination
[(22); present data], we next wanted to determine whether
failure of the Rfa1-Ddc2 interaction in rfa1-t11 was respon-
sible for the type II recombination defect in this mutant.
Because we were conﬁdent that fusion proteins implicating
Rfa1-t11 could be reliable, as seen above, we decided to
use an Rfa1–t11–Ddc2 fusion protein to target Mec1-Ddc2
at the sites of telomeric damage. First, we determined
whether the hybrid protein could rescue the checkpoint defect
of the rfa1-t11 mutation in the cdc13-1 background (58). We
did not expect to rescue the lethality conferred by the absence
of DDC2 (59–61) with this chimeric protein, but only aimed
at trying to restore Rfa1-t11’s defect in Ddc2 binding without
interfering with other Ddc2 functions. Consequently, these
experiments were performed in a DDC2
+ background.
cdc13-1 rfa1-t11 cells expressing the rfa1-t11-DDC2 fusion
construct clearly grew less at 29 C than when expressing
the plasmid alone, but still grew better than cdc13-1 cells,
thereby suggesting partial re-establishment of a functional
DNA damage checkpoint (Figure 5A).
Improved growth of cdc13-1 cells can result not only from
checkpoint inactivation, but also from diminished amounts of
damaged DNA, such as in exo1D mutants, for instance (62).
Since RPA is likely to readily affect processing of damaged
DNA and to control exonucleases, we set out to assess check-
point activation in a different manner. The phosphorylation
state of Rad53, an event that reﬂects its activation (63,64),
was visualized by western blotting using anti-HA antibodies
in strains in which a RAD53-HA fusion gene had been intro-
duced at the RAD53 locus. As expected, Rad53 was massively
phosphorylated in cdc13-1 mutant cells at 34 C, but not at
24 C, and this signal was absent in cdc13-1 rad9D cells at
either temperature (Figure 5B). In cdc13-1 rfa1-t11 cells,
Rad53 phosphorylation was intermediate between these two
fully active and inactive states (Figure 5B), in agreement
with the previous ﬁnding that the rfa1-t11 allele is not com-
pletely defective in checkpoint activation (58). Importantly,
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cdc13-1 rfa1-t11 cells bearing the rfa1-t11-DDC2 construct
than in cdc13-1 rfa1-t11 cells expressing the control fusions
or plasmid alone (Figure 5B). Indeed, an additional Rad53
shifted band was present in the former sample compared with
the control samples (Figure 5B). Increased Rad53 activation
in cells expressing the Rfa1–t11–Ddc2 fusion was also
evident from the observation of a decrease in the intensity
Figure 4. Targeting Rad52 at the sites of DNA damage restores type I, but not type II, recombination in tlc1D rfa1-t11 mutants. (A) Pattern of telomeric
recombination in tlc1D rfa1-t11 cells carrying the rfa1-t11-RAD52 fusion construct on a centromeric plasmid. Left two panels: Seven different isolates from tlc1D
rfa1-t11 p-rfa1-t11-RAD52 (lanes 3–9 in both panels) plus a wild-type, non senescing, strain (lane 1 in both panels) and a tlc1D strain having recombined with a
type I (lane 2 in both panels) are illustrated. Cells were grown in liquid cultures for about 200 generations, at 29 C, after the senescence crisis and processed for
Southern blot analysis using either a telomeric TG1–3 (leftmost panel) or Y0 probe (rightmost panel) following DNA digestion with XhoI in both cases. In leftmost
panel, non-recombining DNA fragments, that appear to be non-Y0 fragments have been labeled with a black dot on the leftmost panel. These bands were not
detected when the blot was re-probed with a probe detecting Y0 sequences (rightmost panel). Middle panel: Genomic DNAs from the same cells as those shown
above in the left two panels were digested with a mixture of restriction enzymes (AluI, HaeIII, HinfI and MspI) using a 4 bp recognition sequence and the
Southern revealed with a TG1–3 probe. This allowed to discriminate between type I and type II recombination because these enzymes do not cut within TG1–3
sequences (16). The slow migrating bands (labeled with the black dots in the leftmost panel) were no longer visible on the four base cutter blot, indicating that
these bands are not the result of some limited type II recombination. DNAs from type II (lane 1) or type I (lane 11) survivors from a tlc1D strain are shown for
comparison. Right panel: Overexpression of RAD52, from a 2 m episomal plasmid under the control of native promoter also rescued telomeric recombination
in tlc1D rfa1-t11 cells. Only type I survivors were recovered. (B) tlc1D rfa1-t11 cells expressing the rfa1-t11-RAD52 fusion from a centromeric plasmid (or the
rfa1-t11-HA control or plasmid alone), as indicated, or expressing RAD52 from a low-copy (centromeric) plasmid (row 3) or from a multi-copy (episomal)
plasmid (row 6), were propagated in liquid cultures for 10 days, at 29 C, with a dilution to 10
6 cells/ml every 24 h, before re-streaking on plates to assess
survival. Both YCp-rfa1-t11-RAD52 and YEp-RAD52 (but not YCp-RAD52) restored telomeric recombination, which, in both cases, was of type I (data not
shown). No survivors were generated in the absence of RAD51 (row 5). Therefore, type I recombination in tlc1D rfa1-t11 p-rfa1-t11-RAD52 cells is conventional
in the sense that it is Rad51-dependent.
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indicated that the Rfa1–t11–Ddc2 fusion protein is capable
of restoring, at least partially, the DNA damage checkpoint.
We next asked whether the rfa1-11-DDC2 construct could
cure the rfa1-t11-associated telomeric recombination defects.
tlc1D rfa1-t11 cells bearing the rfa1-t11-DDC2 construct
were unable to generate any survivors at all (Figure 5C), as
observed in tlc1D rfa1-t11 cells under identical conditions
(Table 3; Figure 4B). Thus, partial rescue of Rfa1-t11’s
checkpoint defect by the Rfa1–t11–Ddc2 fusion protein does
not result in concomitant rescue of telomeric recombination.
At this point, we hypothesized that the interaction between
RPA and Mec1-Ddc2 might be important for operating some
processes only of type II recombination. We therefore set
out to provide rfa1-t11 mutants with a functional Rad52
machinery and determine whether the rfa1-t11-DDC2 fusion
could now make type II recombination work. tlc1D rfa1-t11
cells co-expressing RAD52 and the rfa1-t11-DDC2 fusion
could generate type I survivors, as observed above with the
rfa1-t11-RAD52 construct alone, but were still unable to
produce type II survivors (data not shown). These data sug-
gest that the telomeric recombination defect conferred by
rfa1-t11 does not result from improper recruitment of Ddc2-
Mec1 at damaged telomeres. Moreover, a functional interac-
tion between RPA and the Mec1-Ddc2 checkpoint complex
does not appear to play any role in promoting the functioning
of the Rad51-dispensable type II recombination, even when
functional Rad52 is present.
RPA might compete with Cdc13 for the occupancy of
the telomeric TG1-3 substrate
cdc13-1, a temperature-sensitive mutation in CDC13, coding
for a single-stranded telomeric DNA-binding protein exhibit-
ing afﬁnity exclusively for TG1–3 sequences (65), generates
large stretches of single-stranded telomeric DNA at semi-
permissive and restrictive temperatures (30). We reasoned that
making more telomeric TG1–3 substrate available within the
Figure 5. Restoration of rfa1-t11 checkpoint defect by targeting of Ddc2 does not correct the rfa1-t11-induced defect in telomeric recombination. (A) Growth
of cdc13-1 rfa1-t11 strains transformed each with a centromeric plasmid expressing the indicated fusion construct at 29 C. Growth of checkpoint-proficient
cdc13-1 (lane 1) and checkpoint-deficient cdc13-1 rad9D (lane 2) mutants is shown for comparison. Rescue of the checkpoint defect of cdc13-1 rfa1-t11
by plasmid bearing rfa1-t11-DDC2 is suggested by re-acquisition of the cdc13-1-induced growth arrest at 29 C. See text for explanations. (B) Activation of
Rad53 assessed by visualizing electrophoretic mobility alterations after western-blot analysis of immunoprecipitated cell extracts using anti-HA antibodies.
Strains of the indicated relevant genotype were grown at the temperature of 24 or 34 C (permissive or fully restrictive for growth of cdc13-1 cells, respectively).
The non-phosphorylated Rad53 band, as well as the first two bands of phosphorylated Rad53, representing the first two levels of activation of Rad53, are
indicated by bars in the right margin. Additional bands representing higher levels of activation of Rad53 could also be detected in the cdc13-1 control (lane 2 of
34 C). All strains carried endogenous RAD53-HA integrated at the RAD53 locus. See text for explanations. (C) The rfa1-t11-DDC2 fusion construct (expressed
from a centromeric plasmid) did not restore defective recombination in tlc1D rfa1-t11 mutant cells. Cells were propagated in liquid cultures for 10 days, at 29 C,
with a dilution of the cultures to 10
6 cells/ml every 24 h. tlc1D rfa1-t11expressing p-rfa1-t11-HA were used as a control.
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by the rfa1-t11 mutation. Although a null mutation in RAD17
(coding for a member of the Mec3 complex) affects type II
recombination in a tlc1D background, as seen above, it had
no apparent effect on type II recombination in the cdc13-1
tlc1D background (Table 3; Figure 6), in agreement with
previous results (6). We next conducted similar experiments
using the rfa1-t11 mutation. In the cdc13-1 tlc1D rfa1-t11
strain, survivors were generated at the 10
5 cells/ml dilution
(Table 3). By Southern analysis, telomeres of the cdc13-1
tlc1D rfa1-t11 strain were of type II (Figure 6A). Therefore,
presumably, the increase in single-stranded telomeric DNA
provoked by the cdc13-1 mutation compensates for the
defects conferred by the mec3D, rad17D and rfa1-t11 muta-
tions in type II recombination by providing more TG1–3 sub-
strate normally masked by Cdc13, as previously proposed (6).
Interestingly, the cdc13-1 tlc1D rfa1-t11 rad17D survivors
displayed type I telomeres (Figure 6). The most likely
explanation is that the rfa1-t11 and rad17D mutation impinge
on type II recombination in an additive manner, acting in
Figure 6. The cdc13-1 mutation corrects the rad17D- and rfa1-t11-induced defects in telomeric recombination. (A) Telomere structure and organization of one or
several representative survivors of the indicated relevant genotype. Survivor type after culturing in liquid medium for around 150 generations, as determined
by usual criteria (see Materials and Methods and Figure 1A), is indicated for each strain below each lane. In all three panels, lane 1 is from a wild-type (wt)
non-senescing control. See text for explanations. (B) Strains of the indicated relevant genotype were grown for 12 days in liquid cultures at 25 C and diluted
every 24 h to 10
5 cells/ml. Every day, cells were spotted on agar plates to assess survival. After post-senescence survival had been attained for all strains, on day
12, cells were prepared for determination of survivor type, indicated for each strain on the right, by Southern (data not shown). In both A and B, XhoI cutting and
aT G 1–3
32P-labeled probe were used.
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only possible mechanism.
We next asked whether Mec1 was acting through the RPA
pathway or the Mec3-Ddc1-Rad17 pathway. To answer this
question, we set out to analyze the effects of combining
the mec1D sml1D and rad17D mutations, as well as the mec1D
sml1D and rfa1-t11 mutations, both in a cdc13-1 tlc1D
background, and asked which one of these mutants would
behave like the cdc13-1 tlc1D rfa1-t11 rad17D mutant in
which cdc13-1-induced type II recombination is no longer
possible, as seen above. The cdc13-1 tlc1D mec1D sml1D
rad17D mutant generated type II survivors, just like the
cdc13-1 tlc1D mec1D sml1D control (Figure 6A, middle
panel). Unfortunately, we could not analyze the cdc13-1
tlc1D mec1D sml1D rfa1-t11 survivors because this strain
was inviable. However, the ﬁnding that combining the mec1D
sml1D and rad17D mutations now results in type II recomb-
ination, unlike that of combining the rad17D and rfa1-t11
mutations (Figure 6A, left panel), strongly suggests that Mec1
functions in the same pathway as the Mec3–Ddc1–Rad17
complex, or at least in an overlapping pathway, in these
processes.
We attempted to use the same logic to determine in which
pathway of telomeric recombination control Clb2 was act-
ing. To this end, various mutant strains combining a clb2D
mutation and the mec1D sml1D, rfa1-t11 or rad17D muta-
tions, all in the cdc13-1 tlc1D background, were constructed.
The analysis of the type of telomeric recombination in these
mutants, shown in Figure 6A, indicated that they all gener-
ated type II survivors. This data suggests that the Clb2 path-
way may overlap with both the RPA, Mec1 and Mec3
pathways.
RPA’s checkpoint and recombination functions
are genetically separable
The ﬁnding above that Rfa1-t11 with a partially restored
checkpoint function still conferred complete defect in telom-
eric recombination suggested that these two functions of RPA
might be distinct. To address this point, we set out to isolate
rfa1 mutants that, unlike rfa1-t11, which is deﬁcient in both
the checkpoint and recombination functions, would be defec-
tive in either one (see Materials and Methods). We could iso-
late four rfa1 mutants, that we call rfa1-1, rfa1-9, rfa1-10 and
rfa1-11, that were affected in telomere recombination but
remained checkpoint-proﬁcient, on the basis of their ability
to activate Rad53 at a level similar to that in cdc13-1 RFA1
cells (Figure 7A and C; rfa1-12, another mutant isolated
in the same screen is shown as a checkpoint-proﬁcient,
recombination-proﬁcient allele). In agreement with this
observation, these rfa1 mutants did not exhibit signiﬁcant
hypersensitivity to MMS (Figure 7B). Interestingly, these
mutants were speciﬁcally deﬁcient in type I recombination, as
they produced 100% type II survivors in the ‘streak assay’
(Figure 7C), a situation in which, in most strain backgrounds,
including ours,  90% of the survivors are of type I when
grown on agar-based medium (6,16).
DNA sequencing revealed that rfa1-1 and rfa1-9 contained
multiple point mutations (Table 4). We have not been able
so far to identify the mutations responsible for the phenotypes
of the corresponding mutants.
DISCUSSION
Telomere length homeostasis is critical to the maintenance of
a stable genome (2,3). In the absence of telomerase, telom-
eres progressively shorten, thus losing their protective pro-
teins, and eventually fuse together and break during
chromosome segregation, leading to death by senescence
(8). Rare cells survive this telomeric senescence by perform-
ing recombination between telomeric or subtelomeric
sequences (11). In budding yeast, telomeric recombination
can be affected by mutations in DNA polymerases, a helicase,
an exonuclease, a linker histone, telomere end protection pro-
teins, telomere length control proteins, checkpoint protein
kinases, cyclin-dependent kinase, non homologous end join-
ing genes and by mating type (11,20–22,31,37,66–68). The
present data reveal that, upon loss of telomerase function,
the DNA damage sensors Mec1, Rad24 and Mec3 can affect
telomere recombination in a pathway distinct from that initi-
ating the Mec1-Rad53-Chk1 kinase cascade normally culmi-
nating, upon DNA damage, in cell cycle arrest. This study has
also provided insights into how the evolutionary conserved
DNA repair/replication/checkpoint RPA complex is involved
in promoting cell proliferation by controlling telomeric
recombination.
Control of telomeric recombination by DNA damage
checkpoint proteins
Here, we ﬁnd that a subset of checkpoint proteins, namely
Mec1 [also found in a previous study, Ref. (22)], Mec3-
Ddc1-Rad17 and Rad24, are required for optimal operation
of type II telomeric recombination. On the other hand, inac-
tivation of, either RAD9, RAD53 or CHK1 had no impact on
telomeric recombination. Inactivation of one of the latter
genes totally or partially (Rad53 and Chk1 function in paral-
lel pathways both requiring Rad9) prevents activation of the
whole DNA damage response. In particular, the kinase cas-
cade that goes from Mec1 to Rad53 and Chk1 is, of course,
interrupted (40,41). Therefore, the whole checkpoint response
is not required for the correct control of telomeric recombina-
tion by checkpoint proteins. Mec1 kinase activity, which is
absolutely necessary for the functioning of the downstream
checkpoint components (26,48), was indispensable for these
events. This observation leaves open the possibility that
Mec1 could act in these pathways by phosphorylating a mem-
ber of the MRX (Mre11–Rad50–Xrs2) complex or Rad59, as
proposed previously (22). In the present situation, the Mec1-
dependent DNA damage checkpoint response was shown to
branch out early during the process of damage recognition,
initiating two separate pathways, one that results in the
activation of the kinase cascade and cell cycle arrest, the
second one that activates type II recombination. This is not
unprecedented as, for instance, mec1D tel1D double mutants
underwent telomeric senescence (69), while single or double
mutants of the downstream checkpoint components do not.
We propose that Mec1 and Mec3, once loaded onto damaged
DNA, affect its conformation. They might, for instance, bend
it so as to create conformations compatible with access of
proteins subsequently needed for type II recombinational
events, such as Mre11, Rad50, Xrs2, Rad59 or other as yet
unidentiﬁed proteins.
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delay in the processing and repair of broken ends at a DNA
double-strand break, independently of their defect in G2/M
arrest (70). The resulting low survival, not observed in rad9D,
chk1D and pds1D mutants, was also observed in rad17D,
mec3D, mec1D, and noticeably, in rad53D dun1D mutants
(70). On this basis, the mechanisms described here by
which Rad24, Mec1 and Mec3, but not Rad53, control telom-
eric recombination appear to differ from the mechanisms
of resection of sequences at a broken end described by
Aylon and Kupiec (70). Moreover, in the study by Aylon and
Kupiec (70), Rad51-dependent events of recombination were
analyzed, whereas in the present study the defects conferred
by the rad24D, mec3D and mec1D mutations concerned a
pathway of recombination which, in telomerase-negative,
otherwise wild-type, cells, is completely Rad51-independent
(71). At telomeres, some checkpoint proteins have also been
shown to affect the processing of single-stranded DNA that is
produced after cdc13-1-induced telomeric damage (72). It has
now been established that Mec1, Rad53 and Rad9 inhibit
degradation of telomeric DNA by preventing formation of
abnormal single-stranded DNA in these cells, while, on the
opposite, Mec3, Rad17and Rad24 promote degradation oftelo-
meric DNA (73). In fact, human Rad1 and Rad9 (homologues
to S. cerevisiae Rad17 and Ddc1) have indeed been shown to
possess exonuclease activity (74). Therefore, a member of the
Figure 7. Four novel rfa1 mutants, rfa1-1, rfa1-9, rfa1-10 and rfa1-11, that are deficient in telomeric recombination are nevertheless checkpoint-proficient.
(A) Activation of Rad53, a protein kinase with a pivotal role in the DNA damage response, was measured in these four mutants, in the cdc13-1 background
(lanes 3–6) as well as in negative controls (cdc13-1 rad9D, lane 2 and cdc13-1 rfa1-t11, lane 9) and positive controls (checkpoint-proficient cdc13-1 mutants,
lane 1 and cdc13-1 rfa1-t11 expressing RFA1, lane 8), as described in the legend to Figure 5B). rfa1-12 (lane 7) is another mutant isolated in the same mutagenic
screen. (B) rfa1-9, rfa1-10, rfa1-11 and rfa1-12 mutants are not hypersensitive to a genotoxic stress, unlike rfa1-t11 and ddc1D mutants. 10-fold serial dilutions
(from left to right in each row) of cultures of the relevant indicated genotype that have been treated (in liquid) by MMS, as indicated, prior to spotting on agar
plates. (C) tlc1 rfa1 mutants were continuously grown, at 29 C, on agar-based medium immediately after sporulation of the diploids. Cells were re-streaked every
48 h and allowed to reach senescence, after which cells were processed for genomic DNA preparation and determination of the survivor type (‘streak assay’, see
Materials and Methods), an assay in which the vast majority of survivors is of type I (see text for explanations). The rfa1-1, rfa1-9, rfa1-10 and rfa1-11, but not
rfa1-12, mutants were deficient in generating type I survivors in this assay. XhoI cutting and a TG1–3
32P-labeled probe were used.
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involved in controlling telomeric recombination via process-
ing damaged structures speciﬁcally used for Rad50-, Rad59-
dependent recombination.
Although Rad9 also accumulates at double-strand breaks in
a Mec1-dependent manner (75), the rad9D mutation, unlike
the mec1D mutation, was not found here to affect telomeric
recombination. However, it should be noticed that another
study found that Rad9 focus formation was only partially
affected in mec1D mutants (54). In ﬁssion yeast, Crb2 (the
homologue of S. cerevisiae Rad9) also physically associated
with double-strand breaks (76). Recruitment of Crb2 could be
accomplished in the absence of Rad1 and Rad3, (respectively,
Rad17 and Mec1 in S. cerevisiae) but necessitated their pres-
ence to remain attached (76). Therefore, the physical pres-
ence of a checkpoint protein at the sites of damaged DNA
is not a sufﬁcient criterion to take into account as determining
a positive action on type II recombination. The Mec1 and
Mec3 DNA damage sensors may therefore be endowed
with speciﬁc properties that entitle them to affect type II
recombination.
In telomerase-negative, otherwise wild-type, cells, type II
recombination takes place on TG1–3 repeats and is operated
via the MRX complex, Rad59 and Rad52 (11,56,71). Type II
recombination is interesting on a mechanistic point of view
because it does not require the intervention of the Rad51
recombinase, the only protein capable of strand invasion
during homologous recombination. Rolling-circle replica-
tion primed by an intrachromosomal telomeric D-loop has
been proposed as the basis for type II recombination
(11,12,17,71,77). The observation made here that cdc13-1
rescues the rad17D-induced defect in type II recombination
demonstrates the possibility of efﬁcient recombination on
TG1–3 sequences in the absence of the Mec3 complex. This
strongly argues that the unusual predominance of type I sur-
vivors in tlc1D mec3D cells is due to the impairment of
the Rad50 pathway in the absence of Mec3 rather than to
an impairment of recombination per se. Noticeably, type II
recombination in tlc1D rad17D was restored after RAD51
had been deleted, leaving open the possibility that Rad51
might inhibit type II recombination in wild-type cells and
that deletion of a member of the Mec3 complex might affect
telomeric recombination through changing Rad51 levels.
However, control experiments indicated that variations in
Rad51 levels, induced by overexpressing RAD51, had no
effect on telomeric recombination and were, therefore, proba-
bly not responsible for the observed defect in type II recomb-
ination in these mutants. Since Rad52 is essential for type II
recombination, unlike MRX and Rad59, which can substitute
for each other in this process (56,71,78), it has been specu-
lated that Rad52 might perform the annealing activity invol-
ved in D-loop formation (78). Clearly, however, Rad52
cannot be the defective target in mec1D and mec3D mutants,
as if this was the case, then these mutants would also be
deﬁcient in type I recombination, Rad52 being essential for
both types of recombination.
An important step towards elucidating the processes ana-
lyzed here was the observation that CLB2 overexpression
could rescue the type II recombination defect conferred by
a mutation in the Mec3 complex. These data establish that
the cell cycle machinery can impinge on recombinational
repair, thus conﬁrming several recent data, including the ini-
tial one (79) and one on telomeric recombination (31). Since
Cdc28-Clb2, homologue to Cdk1-cyclin B, rescued a null
mutation in DDC1, it is not likely that it stimulated the
recombination function of the Mec3–Ddc1–Rad17 complex
by acting upstream of it. However, Cdc28-Clb2 might act by
increasing the intensity of the signal contributed by Mec1.
Indeed, it should be noted that our data indicate that Mec1
and Mec3 are both required for the control of telomeric
recombination and that, consequently, they perform distinct
functions in these processes. The possibility of such a sce-
nario is rendered likely by the recent demonstration that
ectopic CLB2 overexpression resulted in direct activation of
Tel1 (80). Alternatively, larger amounts of Cdc28-Clb2 than
usual might activate a component of the recombinational
machinery that is normally put in place by the action of the
Mec3 complex, thus bypassing the need for Mec3-induced
chromatin modiﬁcations. In the same vein, it is possible
that Cdc28-Clb2 directly affects Rad51, inhibiting it for
instance, rather than acting on the Mec3 complex, either
upstream or downstream of it. In this scenario, the Mec3
and Cdc28–Clb2 complexes would affect telomeric recomb-
ination independently of each other, but modifying the
dosage of the other complex could then counterbalance any
effect of either one of these complexes on Rad51.
Our data do not eliminate the possibility that increased dos-
age of CLB2 might indirectly act by affecting the position of
telomerase-negative cells in the cell cycle, possibly enriching
a stage favoring type II recombination. For instance, the
Cdk1-cyclin B complex has been shown to inﬂuence recom-
binational repair during the G2 phase (79). However, it should
be noticed that, unlike constitutive CLB2 overexpression that
causes strong mitotic delay or even arrest (81), overexpres-
sion of CLB2 under the control of its native promoter has
no apparent effect on cell cycle progression (N. Grandin
and M. Charbonneau, unpublished data). We did not observe
signiﬁcant changes in endogenous Clb2 levels in the absence
of the Mec3–Ddc1–Rad17 complex. Even if the slight
decrease in overproduced Clb2 levels observed in ddc1D
tlc1D mutants also takes place in cells expressing endogenous
levels of Clb2 but remains undectable, it seems unlikely
that such a variation could affect telomeric recombination,
because it is only in the complete absence of Clb2 that a
defect in type II recombination could be observed. Finally,
the slight decrease in overproduced Clb2 levels induced by
DDC1 deletion might reﬂect an effect of the inactivation
of the checkpoint on cell cycle position resulting in slight
changes in CLB2 expression.
Control of telomeric recombination by RPA
To our knowledge, the role of RPA in mediating telomeric
recombination had not been previously studied and the
present work therefore provides a platform for further studies.
Table 4. Sequence analysis of the amino acid changes in the rfa1-1 and
rfa1-9 alleles
Rfa1-1:I89T,T116S,S160P,D240G,T346P,D415N,D465V,T510S,E562G,
Y575C
Rfa1-9: S108P, H299D, N310S, V317I, N368Y, S487T, Q571R
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recombination using the rfa1-t11 mutant allele (encoding
Rfa1-K45E) because it has been well documented in other
contexts, not only in DNA repair but also in checkpoint path-
ways (24,50,52). Several conclusions can be made based on the
new phenotypes of rfa1-t11 cells observed in the present study.
rfa1-t11 resulted in impairment of both type I and type II
recombination. Importantly, however, type I recombination
in rfa1-t11 mutants (only possible at decreased dilutions
during passages) atypically relied on Rad59, thus stressing
the plasticity of these recombinational pathways. This also
conﬁrms that rfa1-t11 confers complete impairment of the
Rad51 machinery (15,50). The Rfa1–t11–Ddc2 fusion protein
partially restored the checkpoint but did not facilitate the gen-
eration of type II recombination. The recombination defect
caused by rfa1-t11 was more severe than that caused by the
absence of a DNA damage sensor. The Rfa1–t11–Rad52
fusion protein restored normal, Rad51-dependent, type I
recombination in rfa1-t11 cells, but not type II recombina-
tion. The cdc13-1 mutation rescued the defects in type II recom-
bination conferred by rfa1-t11. Elimination by rfa1-t11 of
cdc13-1-induced type II recombination in cdc13-1 tlc1D
rad17D cells (Figure 6) seems to indicate that rfa1-t11
and rad17D have an additive effect on type II recombination.
Moreover, based on genetic arguments illustrated in Figure 6,
Rad17 and Mec1 appear to function in the same pathway of
telomeric recombination control or, at least, in overlapping
pathways, while Cdc28-Clb2 might function in a pathway
that overlaps with both the Mec1, Mec3 and RPA pathways.
Although expression of fusion (hybrid) proteins may pro-
duce anomalous results under certain circumstances, it should
be stressed that it has been previously used with success
in studies on telomeric processes (38,57). Noticeably, one
of the telomeric proteins of the protein fusion pairs used in
these previous studies was Cdc13, which, like Rfa1 used
here, is a single-strand DNA-binding protein (65). In the
present study, overexpression of RAD52 gave similar results,
thus comforting the experiments using the rfa1-t11-RAD52
and rfa1-t11-DDC2 chimeric genes.
The production of abnormally high levels of single-
stranded DNA at telomeres in cdc13-1 cells (30) was presum-
ably the cause for the rescue of type II recombination in
mec3D, rad17D and rfa1-t11 cells (Table 3; Figure 6). It is
possible that increased single-stranded DNA allows more
RPA to be recruited at damaged telomeres, thereby counter-
balancing the defect caused by the rfa1-t11 mutation. Increa-
sed efﬁciency of type II recombination in the cdc13-1 mutant
background has been previous observed (6). We propose two
possibilities to explain the rescue of type II recombination by
cdc13-1 in rfa1-t11 cells. In the ﬁrst scenario, Rfa1-t11 would
not bind enough TG1–3 sequences, which would result in a
failure to recruit the Mre11–Rad50–Xrs2 complex, needed
for type II recombination. This would be a speciﬁc character-
istic of Rfa1-t11 towards this type of DNA because Rfa1-t11
normally binds other types of single-stranded DNA, in vitro
(82). In the second scenario, Rfa1-t11 would normally bind
the telomeric TG1–3 DNA but would be defective in binding
Mre11-Rad50-Xrs2. In both situations, increasing the amount
of single-stranded TG1–3 DNA via expression of the cdc13-1
mutation would correct either defect by increasing the amount
of Rfa1-t11, which although defective, would eventually
become functional due to the increase in its amounts. Some-
how unexpectedly, type II survivors were no longer generated
when the control of recombination became too defective, due
to the simultaneous mutations in Rfa1 and Rad17 in cdc13-1
rad17D cells and type I survivors were generated instead.
This observation that there is at least one possible condition
that allows the generation of type I survivors in a cdc13-1
background again underlines the remarkable plasticity of
these recombinational pathways.
The failure of the only one documented checkpoint-
deﬁcient mutant protein, Rfa1-t11, to recruit Mec1-Ddc2
(23) also confers an intrinsic recombination defect, due to the
fact that Mec1 affects type II recombination [(22); present data].
The present ﬁnding that expression of an Rfa1-t11-Ddc2
hybrid protein partially re-established checkpoint signaling in
cdc13-1 rfa1-t11 cells without concomitant rescue of recomb-
ination, in tlc1D rfa1-t11, suggested that RPA-t11’s defect
in type II recombination not only stems from its defect in
recruiting Ddc2, but is also due to a defect in a distinct
pathway. Interestingly, the experiments in which cells over-
produced RAD52 in addition to the Rfa1–t11–Ddc2 fusion
suggest that this latter pathway necessitates something else
than Rad52 competent in Rad51-mediated events of recom-
bination. The putative formation of D-loops by Rad52,
presumably required for Rad50-, Rad59-mediated type II
recombination (11,15), might not involve as tight and direct
interactions between RPA, Rad52 and MRX as those between
RPA, Rad51 and Rad52 during strand invasion. The present
data do not preclude the likely possibility that the function
of Mec1 in controlling telomeric recombination necessitates
its recruitment by RPA. Our data may also suggest that the
defect of the DNA damage sensors mutants mec3D and
rad17D in generating type II recombination is not due to
the absence in these cells of RPA–Ddc2 interactions. Finally,
the present study also provides rfa1 alleles that are deﬁcient
in telomere recombination but proﬁcient in checkpoint func-
tion and that may be useful in some biochemical or genetic
assays. These alleles, rfa1-1, rfa1-9, rfa1-10 and rfa1-11,
may confer a speciﬁc defect in type I recombination. Alterna-
tively, they may confer a defect in the processing of dama-
ged DNA, so as to alter the nature of the substrate used for
telomeric recombination. In this latter hypothesis, these rfa1
mutants would behave like cdc13-1 or yku70D mutants,
which, presumably because they accumulate abnormal levels
of telomeric single-stranded DNA, also abnormally generate
exclusively type II survivors during growth on semi-solid
medium (37). Recombinational telomere elongation, which
at the moment is best understood in yeast, appears to be
involved in a subset of human cancers and its study in yeast
is therefore important for biomedical research.
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